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Abstract
Background: Former studies have pointed to a monocyte-dependant effect of antibodies in protection against malaria and
thereby to cytophilic antibodies IgG1 and IgG3, which trigger monocyte receptors. Field investigations have further
documented that a switch from non-cytophilic to cytophilic classes of antimalarial antibodies was associated with
protection. The hypothesis that the non-cytophilic isotype imbalance could be related to concomittant helminthic
infections was supported by several interventions and case-control studies.
Methods and Findings: We investigated here the hypothesis that the delayed acquisition of immunity to malaria could be
related to a worm-induced Th2 drive on antimalarial immune responses. IgG1 to IgG4 responses against 6 different parasite-
derived antigens were analyzed in sera from 203 Senegalese children, half carrying intestinal worms, presenting 421 clinical
malaria attacks over 51 months. Results show a significant correlation between the occurrence of malaria attacks, worm
carriage (particularly that of hookworms) and a decrease in cytophilic IgG1 and IgG3 responses and an increase in non-
cytophilic IgG4 response to the merozoite stage protein 3 (MSP3) vaccine candidate.
Conclusion: The results confirm the association with protection of anti-MSP3 cytophilic responses, confirm in one additional
setting that worms increase malaria morbidity and show a Th2 worm-driven pattern of anti-malarial immune responses.
They document why large anthelminthic mass treatments may be worth being assessed as malaria control policies.
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Introduction
Deciphering the interactions between the malaria parasite with
the human host and understanding how we acquire immunity to
malaria has been fundamental to our malaria vaccine research
program. Over the course of the program, we have extensively
studied the characteristics of immune responses of children and
adults to malaria [1]. In particular, the distribution of IgG
antibody subclasses has led us to suspect the role of helminthic
infections on acquisition of immunity to malaria [2]. A cascade of
observations led progressively over time to corroborate this
suspicion.
The pattern of acquisition of resistance to malaria and the role
of antibodies should be reminded first. Children in hyperendemic
areas are at high risk of dying from malaria until the age of 5.
Though this risk then decreases, they remain susceptible to
malaria attacks until they reach the ages of 15–20 years [3]. By the
time they are young adults, those who have survived achieve a
remarkable state of premunition where they are able to control
parasite growth below the threshold at which clinical symptoms
occur [4]. They have acquired immunity, but at remarkably low
speed. It has been conceptually difficult for a long time to
understand the reason for this long delay: the question being how
malaria antigens could be so poorly immunogenic that daily
exposure to outstandingly high parasite loads for many years
would be required before individuals are protected against the
disease.
This immunity is due to antibodies. Protection can be induced
by passive transfer of IgG from malaria-immune adults to malaria
patients [5]. In order to understand the underlying mechanism we
compared antibody responses between those protected and those
not protected [6]. We found this protection to be associated with a
novel immune mechanism we called ‘‘Antibody Dependant
Cellular Inhibition (ADCI)’’ in which effective antibodies act in
a monocyte (MN)-mediated manner [7]. The ADCI assay
measuring this potential protective immune mechanism has been
used to screen a genome-wide expression library in which MSP3
was identified as the main target of antibodies mediating ADCI
[8]. GLURP (Glutamate-rich Protein) and SERP (Serine-stretch
or Serine-rich Protein) were later identified as additional targets
[9,10]. In our efforts to better characterize the molecular events
leading to ADCI activity, we observed that only minute amounts
of antibodies in the range at which hormones act, were required
[11]. We further found that, in ADCI, an essential component of
the MN mediated antiparasitc effect is the synergistic activation of
monocyte receptors Fcc RIIa and Fcc RIIIa by cytophilic classes
of IgG bound to at least a bivalent antigen [11]. This evidence of
the essential trigerring role of cytophilic classes of antibodies,
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and activate monocytes, led us subsequently to investigate the
isotype distribution of antimalarial antibodies [12].
These studies, the first of their kind, showed that, in contrast to
current beliefs, immune responses were not absent in non-
protected individuals. In fact, they were present and abundant,
but were qualitatively different. Among non-protected individuals,
aged 1–10 and up to 15 years, non-cytophilic classes of antibodies
IgG2, IgG4, and IgM were the most abundant. This stood in stark
contrast to responses in protected adults who had twice as much
cytophilic IgG1 and IgG3 sub-classes compared to the noncyto-
philic classes [12]. In other words the balance of antibodies is more
critical for protection than their abundance. This indicated that
those protected individuals had acquired the ability for an IgG
class-switch from a predominantly non-cytophilic to a cytophilic
predominance. Further studies pin-pointed IgG3 against MSP3 as
the antibody response most strongly associated with protection [1].
The identification of an IgG class-switch associated with the
acquisition of protection, also provided, for the first time, a
plausible explanation for the abnormally long delay needed to
acquire immune protection. The long delay was not due to the
need to accumulate high titers of antibodies to every antigen, but
that required to achieving an Ig class switch. Simultaneously, this
finding provided a biological target for developing a malaria
vaccine, the induction of cytophilic antibodies in young children.
This, in turn raised the question of why children and
adolescents were producing a majority of non-cytophilic classes
of antibodies. The possibility that this was merely due to an
immaturity of the immune system during childhood and
adolescence seemed unlikely. We considered the fact that, children
often differ from adults in malaria endemic areas by the
outstandingly high loads of worms they harbour [13]. Indeed,
high helminthic loads are known to be associated with a Th2/Th1
imbalance [14] and therefore, could be responsible for a worm-
induced Th2 cytokines-mediated drive upon immune responses
directed to malarial antigens, over childhood and adolescence.
To explore the possibility that helminthic infections may have
an effect on acquisition of clinical immunity against malaria, we
initiated several studies on worm-malaria interactions. Most of
them indicated a deleterious role of worms on malaria immunity
[2]. In an intervention study in Ankazobe (Madagascar) which
compared malaria attacks occurring in children 2–15 years of age,
harbouring intestinal worms, who were randomly assigned to
receive either the anthelminthic levamisole or a placebo, a 2.5 fold
decrease in the risk of malaria attacks occurred in the worms-
treated group. Noticeably, this effect became apparent only 18–24
months after worm treatment, which was expected as it implied
the induction of an Ig class switch in B-lymphocytes [2].
Numerous case control studies that compared worm-infected
with worm-free individuals (without anthelminthic treatment),
confirmed a markedly higher incidence of clinical malaria in
wormy individuals and showed that all types of helminths could be
involved, either intestinal parasites, such as Ancylostoma, Ascaris,
Trichuris, Enterobius, or systemic parasites such as Schistosoma mansonii
and haematobium (reviewed in [2,15,16,17]). However, there exists
also studies that have observed the opposite [2,15,16,17]. We feel
that most of these studies failed to include the assessment of the
load of worm. In a study we conducted in Northern Senegal to
look into the interactions between Schistosomiasis and malaria, we
observed that malaria incidence was increased at high and
medium Schistosoma egg-load, whereas at very low egg-loads, a
trend towards the opposite effect was seen [18]. Therefore, when
the other studies have found that adults with worms are still
protected, we contend that this corresponds mostly to adults with
comparatively lower worm loads who have achieved clinical
immunity anyway. In support of this view, most studies of
experimental co-infections in models, in which the worm load is
usually high since it is an induced infection, concluded to their
deleterious influence upon malaria [19,20,21,22], with a single
exception in a rodent model of cerebral malaria [23].
Although the results from the clinical studies indicated a clear
interaction between worm infestations and occurrence of malaria
attacks, they could not address the immunological hypothesis of a
Thelper type 2 imbalance due to worms, either because the groups
were too small to provide significant immunological data or simply
because no biological specimens were available in those retro-
spective studies.
We therefore undertook a prospective study in Casamance,
Southern Senegal, in a cohort of 203 children who were assessed
at the beginning of the study during the non-transmission season,
and closely followed-up for a total of 51 months. Immunological,
epidemiological and clinical data gathered in this manner provide,




The study was designed to be a prospective study aimed at
following a cohort of children 1–14 years of age (mean61SD:
6.963.1) for the occurrence of worms and attacks of malaria over
a 4 year period (51 months).
Study Site
It took place in Mlomp, a village of ca. 8,000 inhabitants in
Casamance, South West Senegal, where the local economy is
based on subsistence farming, rice culture and fishing. Three
similar adjoining suburbs surrounding the local Health care Unit
were selected. All households are built on an identical model
(houses are built with earth-bricks locally produced and are
covered with corrugated iron) and scattered in a similarly forested
environment characterized by a few high trees. The village is
surrounded by numerous rice fields which are a major source of
intestinal helminth infections. At the start of the survey, bednets
were not used by the children, and this was frequently verified
throughout the 51 month follow-up.
Malaria transmission is seasonal, with a low monthly incidence
of malaria attacks in June, which gradually increases up to a
maximum in September, approximately 3 months after the peak of
rainfalls. During the study period, the incidence of malaria
morbididy was 52% and Plasmodium (P). falciparum was present in
more than 95% of the clinical malaria cases. The main vector was
Anopheles gambiae with an estimated 25 infective bites per individual
per year in this village.
Inclusion Criteria
This longitudinal study took place between November 2000 and
January 2005. The cohort was constituded based on an initial stool
examination of 455 children. In order to constitute two sub-groups
of equal size, one with, the other without worms, and paired for
age, i.e. with no age imbalance between the two groups, 238 out of
the 455 children aged 1–14 years could be included in the study
according to those criteria. Thirty-five children could not be
followed-up continuously at each time point, and therefore, only
203 (85.3%) children fulfilled the requirement of continuous
follow-up during the 51 months of survey and were included in the
final analysis
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Committee of Senegal. All patients (or their parents) gave formal
informed consent after detailed explanations given in Diola
language by a local health care assistant and the agreement was
systematically obtained in the presence of a witness from the
village.
Stool Examinations
Stool samples were obtained at enrolment and annually from
each child and screened for eggs and parasites by trained
parasitologists both by microscopic observation of stools, as well
as after using the eggs concentration technique described by
Bailenger [24].
Briefly, stools were diluted 10 times in a dilution buffer (Na
acetate 15g, acetic acid 3,60 ml, in 1000 ml water adjusted at
pH5). After 1 minute of incubation, the stools suspension was
filtered through a metalic mesh and a volume of sulfuric ether was
added to the same volume of filtered material in a centrifuge tube,
and then emulsified by vigorous agitation. Following centrifuga-
tion at 1500 rpm for 1 minute, the pellet was sampled for
microscopic examination. Stools found negative were re-tested a
second time, a few days later.
In Mlomp village, the parasite loads, mostly due to hookworms,
reached an average of 1526 eggs/gramme of faeces, i.e. can be
considered moderate to high.
Stool examinations were repeated every year and individuals
from the negative group who had become positive on year 1 and 2
were treated with 400 mg AlbendazolH. In addition, it was agreed
that, if clinical symptoms associated with helminth infection would
occur, the child would be treated of his parasite infection by the
nurse running the local dispensary.
Finally, on year 3 and 4, in agreement with our initial protocol
and in order to comply with ethical considerations, an anti-
helminthic treatment of 400 mg AlbendazolH was given once a
year to all participants.
Identification of Clinical Malaria Attacks
The incidence of malaria attacks was measured by both active
and passive case detection. Parents were asked to refer children to
the dispensary in case of any abnormal symptom. In addition,
households were visited at least weekly by the medical team
continuously stationed in the village during the transmission
season, so as to ascertain that suspected cases had been referred to
the dispensary. Compliance estimated by weekly visits was high,
particularly as nurses from the dispensary deliver free medical
care. For each single case of fever (i.e. axillary temperature
§37.5uC), a complete clinical examination was performed by a
trained medical staff and under the supervision of the principal
investigator (Dr. P.B.). A thick blood smear was systematically
made and rapidly examined for the presence of malaria parasites.
Slides were stained with Giemsa and examined against 200
leukocytes if positive, or against 400 leukocytes prior to being
declared negative.
A P. falciparum malaria attack was defined by the presence of
both fever and P. falciparum parasites with no clinically apparent
other cause of fever. Children presenting with a malaria attack
were given an antimalarial curative treatment. Intramuscular
quinine injection was given in 95% of the clinical cases, followed
by oral quinine for 4–5 days (25mg/kg/day in three doses). Over
the two last years of the survey quinine was progressively replaced
by artesunate-amodiaquine combination (arsumax
TM and camo-
quin
TM), which accounted the last year for about 50% of the
treatments. Recovery was considered as a further indication that
the febrile episode was indeed an actual clinical malaria attack.
From these data, prevalence, incidence density per time unit
(month, 6 months, year), and geometric mean annual incidence,
used to express the risk of malaria in the study population were
calculated.
No case of complicated malaria was recorded in the cohort of
children enrolled for this study during the entire follow-up.
Sera Samples and ELISA Assays
Sera samples were obtained by venous puncture at the start of
the survey (in November 2000) from each child of the cohort and
the parasite-specific antibody contents from this first year blood
samplings were evaluated by ELISA. Individual sera were tested
for IgG1, IgG2, IgG3 and IgG4 subclasses against various P.
falciparum antigens.
The P. falciparum-derived antigens (amino-acid numbers refer-
ring to 3D7 clone) tested were a) MSP3b(184–210) a 27 AA long
synthetic peptide corresponding to the major B cell epitope of
MSP3 [25], b) MSP3-DG210(163–230), including the same region c)
MSP3-CTerminus(191–354), AMA1 a gift of Dr Robin Anders,
GLURP-R0, a kind gift of M. Theisen [9], and SERP, a kind gift
of Dr. T. Horii [26], the later 5 corresponding to recombinant
proteins.
IgG subclass antibodies to the different antigens were detected
and quantified essentially as previously described [7,27,28].
Briefly, high-binding 96-well microplates (Nunc MaxisorpH,
Denmark) were coated with 5mg of antigen per well. Antigens
were dissolved in PBS and incubated overnight at 4uC. The
optimal serum dilution was determined to be 1:200 except for
MSP3b, which was tested at 1:50 dilution, as in our previous
studies [1,25,29].
Human subclass specific mouse monoclonal Abs were used and
assayed using peroxidase-labelled goat anti-mouse IgG (at 1:2000)
as previously described [7,27,28]. Optimal concentrations for the
selected reagents were 1:2000 for IgG1 (clone NL16), 1:10,000 for
IgG2 (clone HP6002) and IgG3 (clone ZG4), and 1:30,000 for
IgG4 (clone RJ4 from Skybio, UK). Peroxidase-conjugated
polyclonal goat anti-human IgG (c-chain specific) were diluted
1:10,000.
Antibody responses are expressed as Arbitrary Units obtained
by calculating the ratio of test OD values obtained for a given test
sample divided by a background value defined as the mean plus 3
SD of the absorbance values obtained using a subsample of 40
negative control sera from malaria-naı ¨ve blood donors.
Statistical Analysis of Data
We analyzed the data using the JMPH software and StatviewH 5
softwares, both from SAS Institute (Cary, North Carolina, United
States). We used univariate and multivariate analysis to explore
factors potentially associated with susceptibility to malaria attacks.
P. falciparum-specific humoral responses were tested by two
successive approaches. Firstly, the pattern of parasite-specific
antibody responses was evaluated with regard to the presence or
absence of intestinal helminths (used as a dichotomous variable) in
univariate tests. Then, age and parasite-specific antibody responses
were used as continuous explanatory variables in nominal logistic
regressions. Secondly, the pattern of P. falciparum-specific humoral
responses was determined with regard to the occurence or non-
occurence of malaria attacks during the 51 months of follow-up. In
additional studies, the (Log+1)-transformed total number of
clinical episodes was used as a continuous variable and the
explanatory variables included in multivariate analysis were age
sex, household/family and the antibody responses, expressed as
Log-transformed arbitrary units as in previous studies [1,25,29].
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antibodies to some of the parasite antigens tested were less
susceptible to clinical malaria and b) children without worms
differed from children with helminths in term of relative
susceptibility to malaria. The different helminth infections
observed were initially grouped in one single binary exposure
variable corresponding to the presence or absence of helminth
infection. We also looked for a potential individual effect of some
specific type of infections after identification of the infecting
parasite species. We first looked at the 2 subgroups separately
using non-parametric tests to analyze non-Gaussian variables,
whereas variables with normal distribution were tested by
parametric tests. Multiple linear regression models were used to
determine the potential effect of different explanatory variables
(such as age and P. falciparum-specific antibody responses) on the
significance of the comparisons. A stepwise logistic regression
model retaining explanatory variables with P values less than 0.05
in the initial study was used to reduce the number of explanatory
variables tested in the full model.
Results
Incidence of Malaria Attacks and Prevalence of Intestinal
Helminth Infections in the Study Population
The 203 children from Mlomp had a mean age of 6.963.1
years (range: 1–14 years) at enrolment in the year 2000. At
baseline, children without intestinal helminths (n=98) were
6.863.4 years old (range: 1–13 years) whereas children with
worm infections (n=105) were 7.062.9 years old (range: 1–14
years), i.e. the 2 subgroups of children did not differ for age. Three
years after the start of the follow-up, the weight of the children was
comparable between the 2 subgroups (26.569.7 kg versus
28.7611.3 kg, in the group without and with intestinal helminths
respectively). The sex ratio was similar in the two subgroups with
46.8% males.
Over the duration of the study, the prevalence of malaria
attacks peaked three months after the end of the rainy season (not
shown). The monthly prevalence of symptomatic malaria episodes
ranged from 0% in May 2001 up to 13% in November of the same
year. The geometric mean annual incidence rate of malaria attacks
per child was 0.614 (95% CI=0.503–0.734).
During the 51 months period of active and continuous survey,
47 out of 203 children (23.1%) had no detectable episode of
symptomatic malaria diagnosed, whereas 421 malaria attacks were
recorded in the 156 children who experienced between 1 to 9
clinical malaria episodes (mean 6 1SD=2.761.7 attacks/child),
and received first-line treatments. Fourty five children had 1
attack, 42 had 2 attacks, 29 had 3, and 40 had .4 attacks (range
4–9 attacks). The incidence of malaria episodes over the study
period ranged from 81.13% (2.4362.10 attacks/51 months) in 53
children aged 0–4 years, to 72.34% (1.8161.85 attacks/51
months) in 47 children aged 10–14 years.
During the study, and notably during the last two years of the
survey, the occurrence of clinical malaria in the cohort of children
was found to progressively decrease with time (Rho=20.44;
P=0.0014). This was most likely due to a combination of factors
including improved access to medical treatment, introduction of
artesunate-amodiaquine combination [30], and the increase in age
of the children enrolled in the study (Rho=20.127; P=0.069).
105 out of 203 children (51.7%) were found infected at
enrollment and with at least one intestinal helminth species. 60%
of the remaining 98 children initially free of detectable helminthic
infection remained so throughout the study. Fourty percent of
helminth free children became helminth positive over the follow-
up period (3.1% after 1 year, 8.2% after 2 years, 13.3% after 3
years, 15.3% at 51 months), 14 being infected twice.
The most frequent species was hookworm, detected in 87 of the
helminth-infected children. Ascaris lumbricoides was found in 21,
Strongyloı ¨des stercoralis in 17, Enterobius vermicularis and Trichuris
trichiura in 6, and Hymenolepis nana in 3 individuals. Prevalence of
each helminth species did not differ significantly depending on
gender, age, or year of study. A mean number of 1526 eggs per
gramme of stools (range: 40–5800) was determined by the
concentration technique employed, and only 10% of the children
with helminth infections had less than 80 eggs per g of stools,
indicating moderate to high helminthic loads in this cohort of
children.
We addressed the existence of potential differences in spatial
distribution of the prevalence of infections either as a function of
neighbourhood, of household or of family links. Children were
living in 3 main and geographically contiguous areas of Mlomp
and belonged to 6 major family groups living in compounds
similarly structured. As far as this could be evaluated, the everyday
way of life, the social status, the housings and the socioeconomic
indicators were very similar from one family to the other, with
most parents working as agricultors in rice fields surrounding the
village. On the basis of the above parameters, the prevalence of
intestinal helminths, the occurrence of malaria attacks and/or the
delay observed before occurrence of the first malaria attack, did
not show any particular geographic clustering, i.e. these factors
were equally distributed in the different geographic locations of the
children. Of note, in several occasions, both helminth infected and
non-infected children were identified in a same family.
The Incidence of Malaria Attacks Is Increased in
Helminth-Infected Children
The results show that the presence of any helminth species was
significantly associated with an increased risk of malaria attack
(Table 1). During the first year of survey, the incidence density of
malaria attacks was 0.655/child/year when children had intestinal
helminths, whereas it was 0.380/child/year when children were
free of intestinal helminths. The ratio of malaria attack incidence
density between the 2 groups of children was 1.723 (P=0.0215).
Over the first two years of follow-up, children with intestinal
helminths had 1.94360.309 malaria attacks, whereas children
without helminths had 1.18760.107 attacks (P=0.0057).
When comparing 2 similar transmission periods of 6 months at
1 year interval, i.e. in 2000 and 2001, the likelihood of developing
symptomatic malaria was markedly higher for children with
intestinal helminths than for those without detectable helminth
infection (Odds ratio=OR=2.27; 95%CI=[1.12–4.61];
P=0.0218).
After 51 months of follow up, the higher incidence of malaria
attacks remained in helminth-positive as compared to helminth-
Table 1. Relative risk of malaria attacks in children living in
Mlomp village.
RR at 6 months = 1.60 [1.03–2.45] P=0.021
RR at 12 months = 1.72 [1.19–2.42] P=0.021
RR at 24 months = 1.53 [1.11–2.40]; P=0.006
RR at 51 months = 1.24 [1.06–1.43] P=0.004
The relative risk (RR) and [95% Confidence Interval] of malaria attacks was
determined in children with helminth infections compared to children without
helminth infections.
doi:10.1371/journal.pone.0009309.t001
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2 with Yates’correction: 7.32; P=0.0068). OR
and 95%CI were 2.72 (1.35–5.45).
At the end of the survey, Kaplan Meier estimates showed that
28.7% of worm free children had not suffered from clinical
malaria, whereas only 11.7% of helminth positive children, i.e.
2.45 fold less individuals, remained free of symptomatic malaria,
(Log Rank x
2=10.67; P=0.0011).
We further studied this association in a multivariate analysis
using gender, age, presence or absence of intestinal helminths as
explanatory variables. The odds ratios for the occurrence of at
least one episode of clinical malaria were determined after
adjusting for age, sex, and household/family.
All the available variables with a potential impact on malaria
attacks were included in a logistic-regression model. Stepwise
logistic regression analysis starting with a full model retained
helminth infection [odds ratio=2.69; and 95% confidence interval
CI=1.34–5.39; P=0.0045] as the most significant explanatory
variable for an increased risk of malaria attacks whereas age was
weakly associated with a decreased risk of clinical episode (odds
ratio: 0.28, 95%CI=0.06–1.20; P=0.0907).
Thus the association between helminth infections and risk of
malaria attacks remained significant after controlling for potential
confounders. Given that all the children of the cohort lived in a
similar environment and that anti-parasite immune responses were
comparable between the children originating from the different
compounds of Mlomp village (see below), it was considered that
the risk of exposure to malaria was similar for all children.
Therefore, in the present study we conclude that the major risk
factor associated with clinical episodes of malaria was whether or
not the children had detectable intestinal helminthic infection(s) at
the beginning of the 51 months of follow-up
Cytophilic Anti-MSP3 Antibodies Are Associated with a
Reduced Risk of Malaria Attack
Antibodies specific for each malaria antigen tested were
detected in the children. For total IgG, there was no statistically
significant difference in the magnitude of the responses to any
antigen between the two groups, although responses tended to be
higher in the ‘‘protected’’ group (i.e. without malaria attacks) than
in the ‘‘susceptible’’ one (i.e. with malaria attacks). Futher studies
analyzed isotype specific responses to each antigen.
In univariate analysis, children who remained free of malaria
had significantly higher levels of IgG1antibodies, and lower levels
of IgG2 antibodies to total P.falciparum extract than children who
had one or several malaria attacks (not shown). Similarly, children
who remained free of malaria had higher levels of antibodies
against Glurp-R0, SERP and the 3 MSP3-derived antigens than
children of the same mean age who experienced malaria attacks.
In an univariate type of analysis (Figure 1), several IgG sub-classes
to those three antigens were found potentially associated with a
reduced risk of clinical malaria during the follow-up period: anti-
Glurp-R0, anti-SERP and anti-MSP3b IgG1, and IgG3 responses
were higher among children free of malaria. Anti-DG210 IgG1
were also high in children with no clinical attack whereas IgG4
against DG210 and MSP3CT were higher in children with
malaria attacks. In contrast, there was a trend for IgG1 and IgG3
anti-AMA1 levels to be higher in children with malaria attacks
compared to children without clinical malaria attacks.
The potential association between these various antibody
responses and the relative susceptibility to malaria attacks over
the 51 months of follow-up was then tested by multivariate
analysis. The variable that we wished to explain, i.e. the number of
malaria attacks, was tested by taking into account several
potentially explanatory variables including age, together with
antibody responses used as continuous variables. Protection from
malaria attacks was found significantly associated with high anti-
MSP3b IgG1 responses [L-R Chisquare=5.99; P=0.0143], and
independently, with high anti-MSP3b IgG3 responses [L-R
Chisquare=5.33; P=0.0208]. The indications obtained with
MSP3b peptide were confirmed by the use of additional antigens
corresponding to either the C-terminus of the molecule (MSP3-
CT) or to the conserved region of MSP3 (DG210), targeted by
biologically active antibodies. Protection from malaria attacks was
also found associated with high anti-DG210 IgG1 levels (L-R
Chisquare=8.1; P=0.004), high anti-DG210 IgG3 (L-R Chis-
quare=5.1; P=0.027) and low anti-DG210 IgG4 levels (L-R
Chisquare=7.4; P=0.006), as well as with high anti-MSP3-CT
IgG1 responses (L-R Chisquare=6,1; P=0,013), high anti-MSP3-
CT IgG3 responses (L-R Chisquare=4.9; P=0.027), and with low
anti-MSP3CT IgG4 responses (L-R Chisquare=4.4; P=0.035).
Anti-MSP3-CT IgE responses were also tested and found similar
in children with (1.2460.43) and in children without malaria
attacks (1.1160.10; P=0.286). No other antibody specificity
showed a similar association with protection in Mlomp, as immune
responses to AMA1, Glurp-R0 and Serp became no longer
significant in the more stringent multivariate analysis.
Helminthic Infections Significantly Affect the Isotype
Balance of Anti-MSP3 Antibodies
As shown in Figure 2, several antigen-specific isotype responses
were found to be lower in children carrying worms as compared to
children free of intestinal helminth infections. In univariate
analysis, this was the case for anti-Glurp-R0 IgG1, anti-SERP
IgG3 (P=0.056), anti-MSP3b IgG1 (P=0.0013), anti-MSP3b
IgG3 (P=0.0581), anti-DG210 IgG1 (P=0.0126), anti-DG210
IgG3 (P=0.057), anti-MSP3CT IgG3 (P=0.053). IgG4 isotype
responses to DG210 (P=0.018) and to MSP3CT (P=0.026)
followed an opposite pattern, being found at higher levels in
children carrying worms. In contrast, no significant change in the
pattern of anti-AMA1 antibody responses was found associated
with the presence or absence of intestinal helminths.
However, in multivariate analysis, the presence of intestinal
helminths was found to be associated with significantly lower levels
of anti-MSP3b IgG1 (L-R Chisquare=5.27; P=0.013); lower levels
of anti-MSP3b IgG3 (L-R Chisquare=4.72; P=0.029), and
conversely, with higher levels of anti-MSP3b IgG4 antibodies (L-R
Chisquare=6.83; P=0.009). This relationship was also found when
antibodies to DG210 and MSP3CT were tested in similar conditions.
The presence of intestinal helminths was found associated with lower
levels of anti-DG210 IgG1 (L-R Chisquare=6.77; P=0.0093) and
higher levels of anti-DG210 IgG4 (L-R Chisquare=6.99;
P=0.0082). When intestinal helminths were present, lower levels of
anti-MSP3CT IgG1 (L-R Chisquare=4.07; P=0.043), lower levels
of anti-MSP3CT IgG3 (L-R Chisquare=8.27; P=0.004) and higher
levels of anti-MSP3CT IgG4 (L-R Chisquare=7.61; P=0.006) were
detected. Of note the changes in IgG4 responses were highly
significant. The pattern of immune responses identified in helminth
positive children, as compared to helminth negative children, is
coherent with an increased Thelper 2 type of immune response
associated with helminthic infection.
We also investigated anti-MSP3 IgE responses so as to
determine if there existed an association between helminth
infections and the P. falciparum-specific IgE levels. No difference
between worm carriers and worm free children was detectable and
the mean IgE arbitrary Unit was 1.0560.371.
Thus, in total, high MSP3-specific cytophilic responses were
found associated both with a limited number of malaria attacks
and with the absence of intestinal helminths.
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In the present study we found a statistically significant
correlation between three elements, namely: i) worm carriage, ii)
a decrease in cytophilic IgG1 and IgG3 antimalarial response
together with an increase in non cytophilic IgG4, and iii) an
increased occurrence of malarial attacks.
Results obtained in Casamance confirm on the one hand, the
association with protection of anti-MSP3 cytophilic responses [1]
and on the other hand, confirm in one additional setting, that
worms augment malaria morbidity [2]. However, in addition to
previous case/control studies showing a worm-related increase of
clinical malaria, the present study supports for the first time the
initial immunological hypothesis that this clinical outcome is
indeed related to a Th2 worm-driven effect upon anti-plasmodial
responses.
Out of the different antigens studied, the association between
clinical protection and cytophilic responses was found in univariate
analysis for 3 of them, MSP3, Glurp and Serp/Sera, three
molecules known to trigger the Monocyte-dependant mechanism,
though not for the 4
th antigen, AMA-1 which is considered to act
by antibodies inhibiting merozoite invasion. However, as has been
observed in other settings, the association with MSP3 responses
was the strongest and ultimately proved to be the only one
remaining significantly associated with protection in multivariate
analysis. This was confirmed using 3 different constructs derived
from MSP3. As observed previously, the IgG3 isotype of MSP3
antibodies was associated with clinical protection [1,29]. In
contrast with previous findings, the anti-MSP3b IgG1 response
in Mlomp children was also significantly associated with
protection, this being either an age-related and/or a transmis-
sion-related phenomenon. It is reminiscent of the dominant IgG1
response observed in MSP3 immunized European volunteers, and
could be related to the lower transmission conditions prevailing in
Mlomp as compared to previous studies performed in Dielmo for
instance (i.e. IgG1 might constitute the initial antibody response
which would be superseded by IgG3 under higher antigen
stimulation conditions).
In multivariate analysis, helminthic infection was found
associated with an imbalance in favor of non-cytophilic antibodies
Figure 1. Antigen-specific antibody responses and occurence of malaria attacks. Mean reactivity in ELISA assays determined in sera from
children presenting with (malaria attacks+), or without (malaria attacks2) clinical malaria during the follow-up. Sera samples were tested using
different antigens and mean results for AMA-1, SERP-SERA, GLURP-R0, MSP3b, DG210 and MSP3CT are shown with standard errors of the mean IgG
A.U. Labels indicate when differences were found significant in univariate analysis: u when 0.06.p$0.05, * when 0.05,p $0.0021 and ** when
p,0.0021 (a p value of 0.0021 accounts for the multiplicity of tests carried out).
doi:10.1371/journal.pone.0009309.g001
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mediating merozoite invasion-inhibition. Here as well, and in
agreement with the association with protection, the worm-induced
imbalance was significant in multivariate analysis only for anti-
MSP3 antibodies. In this case, both the cytophilic IgG1 and IgG3
responses were decreased, whereas the non-cytophilic IgG4, which
can compete with the former two was significantly increased,
relative to IgG1 and IgG3 levels. This was also consistent using 3
MSP3 constructs. These results indirectly support the importance
of a Fcc trigerred monocyte effect in vivo in exposed individuals.
They also, once more, stress the potential relevance of antibodies
to MSP3, as compared to other ADCI targets, and other vaccine
candidates, a finding consistent with previous studies in other
African and Asian settings [1,29].
Among possible confounding factors, environmental factors can
be likely excluded as in most families, there were both helminth
free and helminth-infected children suggesting a similar exposure
in the household and immediate surroundings. Conversely, the
present observational study does not allow to formally conclude to
a direct causal relationship between hookworm carriage, imbal-
ance towards non-cytophilic antimalarial response and occurrence
of malarial attacks, and does not exclude that genetic factors, for
instance, could also contribute to either one of those 3 parameters.
However, the hypothesis of a causal relation is supported by
observations made in other fields than malaria. The influence of
worms upon non-malaria specific immune responses in human is
actually well documented [31,32,33,34]. For instance, the
deleterious effect of worms is documented in the field of responses
to currently employed vaccines, e.g. those used in the extended
program of immunisation. It is well known that worms can
interfere or impede a proper vaccine-induced sero-conversion, and
vaccine induced protection, particularly for those vaccines such as
tetanus toxoid, tuberculosis, cholera toxin in which protection
relies on Th1 type of responses [31,35,36,37,38]. Helminth
infections are known to drive the immune system towards Th2
type of responses whereas protection against malaria is associated
Figure 2. Anti-MSP3 cytophilic Antibody responses are significantly lower in worm-positive than in worm-free children. Mean
reactivity and standard errors of the mean IgG A.U. obtained in ELISA assays with sera from children harbouring (helminths +), or not (helminths 2)
helminthic infection(s) using different antigens including AMA-1, SERP-SERA, GLURP-R0, MSP3b, DG210 and MSP3CT. Labels indicate when
differences were found significant in univariate analysis: u when 0.06.p$0.05, * when 0.05,p$0.0021 and ** when p,0.0021 (a p value of 0.0021
accounts for the multiplicity of tests carried out).
doi:10.1371/journal.pone.0009309.g002
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infections are also known to induce marked and highly polarized
immune responses characterized by increased Th2 cytokine
production and down-regulated Th1 type immune responses
(19,30,35,40–42).
Findings in rodents, in which similar quantitative and
qualitative immune responses changes were detected, are conver-
gent. Higher parasite loads were reported in helminth-infected
animals [20], increased severity of malaria infections (a non lethal
P. yoelii strain becomes lethal), alteration of innate responses, and a
profound decrease in Th1 responses [22]. Helminthic infections
have also been found associated with a major increase in T-
regulatory cells activity, and a modulation of inflammatory
responses [42,43]. Of note, one study did not illustrate a detectable
impact of worm carriage on a rodent model of cerebral malaria,
suggesting that various experimental host parasite combinations
can yield different results [23]. A recent immuno-epidemiological
study brings support to our findings [44]. Though it did not adress
the susceptibility to disease, nor that of antibody responses, it
indicated deep modifications of cellular responses to a P.falciparum
extract in wormy individuals, leading to a contra-inflammatory
profile of responses. These results confirm in humans our findings
in rodents [22] that worms induce a T-regulatory cell activity with
a reduction of pro-inflammatory type of cytokines, which are
required to generate Th1 responses [44].
Our observations that intestinal worms can affect the quantity
and quality of antimalaria immune responses have implications for
malaria control (treating worm infections could achieve a faster
acquisition of protection against malaria) [2] and for the design of
future malaria vaccine phase II-b efficacy trials, with current
malaria vaccine candidates (worms could be a major confounding
factor, that might deserve to be controlled for in a rigorous
manner).
At least, the detection of every category of helminths, including
a quantification of worms loads, should now be part of the
biological investigations performed during malaria surveys or
phase IIb vaccine trials and be included in the final bio-statistical
model aimed at interpreting results.
We have recently reported, in the village of Dielmo [1] that a
subset of ca. 20% of young children readily developing cytophilic
classes of IgG, was protected early in life against malaria, whereas
the majority, developing predominantly non cytophilic responses,
were prone to repeated malaria attacks until they switched to
cytophilic classes. An attractive hypothesis is that the first group
may differ from the second one by low or absence of worm
infections, and/or associated genetic factors.
Even if this study substantiates the immunological role of worms
in the isotype imbalance seen in the majority of children, it is likely
that it is not the only influence. Several other factors may
potentially contribute to the outcome; for instance, children are
more prone to produce, early in life, IgM non-cytophilic classes of
antibodies in contrast to adults who produce both IgG2 and IgM
non-cytophilic responses. It is also plausible that there are genetic
factors at the origin of a preferential switch towards a particular
class or subclass of antibody. A detailed analysis of the underlying
factors would require large cohort studies as there will be a need to
combine an analysis of the genetic background of human
populations, of parasite populations, and of the almost unlimited
combinations of concomitant infections by parasites, viruses or
bacteria, that are highly prevalent under tropical conditions
[17,45,46]. The resulting multi-factorial equation is obviously
complex to analyze and this is likely the main factor that has
delayed until now the identification of the worm effects upon
malaria.
Our study and the underlying hypothesis bring new elements
contributing to improving our understanding of the dynamics of
P.falciparum/human immune interaction and for the very long
delay required to acquire protective immunity against malaria
related to a dominance of non-cytophilic responses, the latter
being at least in part now attributable to worm carriage
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